GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioLASCO Taiwan Co Ltd (ROCO:6662) » Definitions » EV-to-Revenue

BioLASCO Taiwan Co (ROCO:6662) EV-to-Revenue : 3.00 (As of May. 16, 2024)


View and export this data going back to 2018. Start your Free Trial

What is BioLASCO Taiwan Co EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, BioLASCO Taiwan Co's enterprise value is NT$789.9 Mil. BioLASCO Taiwan Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was NT$263.3 Mil. Therefore, BioLASCO Taiwan Co's EV-to-Revenue for today is 3.00.

The historical rank and industry rank for BioLASCO Taiwan Co's EV-to-Revenue or its related term are showing as below:

ROCO:6662' s EV-to-Revenue Range Over the Past 10 Years
Min: 1.22   Med: 2.69   Max: 6.65
Current: 2.98

During the past 10 years, the highest EV-to-Revenue of BioLASCO Taiwan Co was 6.65. The lowest was 1.22. And the median was 2.69.

ROCO:6662's EV-to-Revenue is ranked better than
72.64% of 1038 companies
in the Biotechnology industry
Industry Median: 7.97 vs ROCO:6662: 2.98

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-16), BioLASCO Taiwan Co's stock price is NT$35.00. BioLASCO Taiwan Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was NT$10.32. Therefore, BioLASCO Taiwan Co's PS Ratio for today is 3.39.


BioLASCO Taiwan Co EV-to-Revenue Historical Data

The historical data trend for BioLASCO Taiwan Co's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioLASCO Taiwan Co EV-to-Revenue Chart

BioLASCO Taiwan Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.02 2.45 2.66 2.56 2.67

BioLASCO Taiwan Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.88 2.61 2.81 2.67 -

Competitive Comparison of BioLASCO Taiwan Co's EV-to-Revenue

For the Biotechnology subindustry, BioLASCO Taiwan Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioLASCO Taiwan Co's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BioLASCO Taiwan Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where BioLASCO Taiwan Co's EV-to-Revenue falls into.



BioLASCO Taiwan Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

BioLASCO Taiwan Co's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=789.869/263.328
=3.00

BioLASCO Taiwan Co's current Enterprise Value is NT$789.9 Mil.
BioLASCO Taiwan Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$263.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BioLASCO Taiwan Co  (ROCO:6662) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

BioLASCO Taiwan Co's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=35.00/10.322
=3.39

BioLASCO Taiwan Co's share price for today is NT$35.00.
BioLASCO Taiwan Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$10.32.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BioLASCO Taiwan Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of BioLASCO Taiwan Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


BioLASCO Taiwan Co (ROCO:6662) Business Description

Traded in Other Exchanges
N/A
Address
3rd Floor, 316 Chong-yang Road, Taipei, TWN, 115
BioLASCO Taiwan Co Ltd is a biological experimental development company. The company has produced strains of laboratory rats and mice, including outbreed stocks, inbreed strains, and immunedeficient models. It offers reagent kit and equipment which include Allentown, Biomedical data system, PLAS LABS.

BioLASCO Taiwan Co (ROCO:6662) Headlines

No Headlines